摘要
本文报告23例大肠原发非何杰金氏恶性淋巴瘤。其特点如下;1.本病少见,占同期收治大肠恶性肿瘤的1.9％。2.男∶女=1.9∶1;平均43.6岁(>41岁占65.3％)。3.升结肠发病多(69.6％)。全组均为B细胞源性NHL。4.本组除1例直肠经咬检术前获明确诊断外,余均为术后病理证实。5.本组5年生存率为31.6％,比大肠癌差。而手术切除率为100％, 又比大肠癌要好。6.浆膜受累,淋巴结转移,病期早晚直接影响预后。7.术后放疗+化疗可使术后单纯化疗的5年生存率从25％提高到50％。
Twenty-three cases of primary non-Hodgkin's malignant lymphomas (NHL) of the large bowel are reported. This kind of tumor comprised only 1.9% of all large bowel malignant tumors encountered. The ratio of male to female was 1.9:1. The mean age was 43.6 years. 69.6% of these tumors located in the ascending colon. All were categorized as B-cell type NHL. All had pathologic evidence. The 5-year survival rate was 31.6% which is lower than carcinoma of the large bowel. The prognostic factors were serosal involvement, lymph node metastases and histological stage of disease. Radiotherapy plus chemotherapy after operation was more effective than single chemotherapy alone. The combined method can increase the survival rate at 5 years from 25% to 50%.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
1992年第3期206-209,共4页
Chinese Journal of Clinical Oncology
关键词
大肠肿瘤
NHL
淋巴瘤
Large bowel
Non-Hodgkin's malignant lymphoma(NHL)
